Human amniotic membrane extracts have anti-inflammatory effects on damaged human corneal epithelial cells in vitro

Han Na Lee, Raymundo Bernardo, Gi Yeon Han, Gyu Young Kim, Ji Soo Kim, Won Yong Jung, Keun Nam Kim, Jae Chan Kim, Chan Wha Kim

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

The human amniotic membrane has therapeutic potential for several diseases such as cardiac ischemia, liver fibrosis, and ocular surface disorders. In the treatment of ocular surface disorders, human amniotic membrane transplantation promotes epithelial wound healing and suppresses inflammation. The objective of this study was to determine whether human amniotic membrane extracts (HAE) help damaged corneal epithelial cells recover from an inflammatory response. Human corneal epithelial cells (hCEC) which were induced inflammation were treated with human amniotic membrane extracts, and then the levels of inflammatory cytokines were measured. Human amniotic membrane extracts had an anti-inflammatory effect on damaged human corneal epithelial cells. More importantly, homogenized human amniotic membrane extracts of less than 3 kDa had a greater capacity for reducing inflammation and secretion of interleukin-6 (IL-6) and interleukin-8 (IL-8). Thus, these results indicate that the use of human amniotic membrane extracts is a promising treatment for ocular surface disorders accompanied by inflammation.

Original languageEnglish
Pages (from-to)282-287
Number of pages6
JournalJournal of Hard Tissue Biology
Volume25
Issue number3
DOIs
Publication statusPublished - 2016

Fingerprint

Amnion
Anti-Inflammatory Agents
Epithelial Cells
Membranes
Inflammation
In Vitro Techniques
Interleukin-8
Liver
Interleukin-6
Liver Cirrhosis
Wound Healing
Cytokines
Ischemia
Transplantation

Keywords

  • Anti-inflammatory effect
  • Human amniotic membrane extract (HAE)
  • Human corneal epithelial cell (hCEC)
  • Interleukin-6 (IL-6)
  • Interleukin-8 (IL-8)

ASJC Scopus subject areas

  • Biochemistry
  • Cell Biology
  • Biomaterials
  • Medicine (miscellaneous)
  • Orthopedics and Sports Medicine
  • Dentistry(all)

Cite this

Human amniotic membrane extracts have anti-inflammatory effects on damaged human corneal epithelial cells in vitro. / Lee, Han Na; Bernardo, Raymundo; Han, Gi Yeon; Kim, Gyu Young; Kim, Ji Soo; Jung, Won Yong; Kim, Keun Nam; Kim, Jae Chan; Kim, Chan Wha.

In: Journal of Hard Tissue Biology, Vol. 25, No. 3, 2016, p. 282-287.

Research output: Contribution to journalArticle

Lee, Han Na ; Bernardo, Raymundo ; Han, Gi Yeon ; Kim, Gyu Young ; Kim, Ji Soo ; Jung, Won Yong ; Kim, Keun Nam ; Kim, Jae Chan ; Kim, Chan Wha. / Human amniotic membrane extracts have anti-inflammatory effects on damaged human corneal epithelial cells in vitro. In: Journal of Hard Tissue Biology. 2016 ; Vol. 25, No. 3. pp. 282-287.
@article{ca7cb338f0454fa1bde6b247b0b386a6,
title = "Human amniotic membrane extracts have anti-inflammatory effects on damaged human corneal epithelial cells in vitro",
abstract = "The human amniotic membrane has therapeutic potential for several diseases such as cardiac ischemia, liver fibrosis, and ocular surface disorders. In the treatment of ocular surface disorders, human amniotic membrane transplantation promotes epithelial wound healing and suppresses inflammation. The objective of this study was to determine whether human amniotic membrane extracts (HAE) help damaged corneal epithelial cells recover from an inflammatory response. Human corneal epithelial cells (hCEC) which were induced inflammation were treated with human amniotic membrane extracts, and then the levels of inflammatory cytokines were measured. Human amniotic membrane extracts had an anti-inflammatory effect on damaged human corneal epithelial cells. More importantly, homogenized human amniotic membrane extracts of less than 3 kDa had a greater capacity for reducing inflammation and secretion of interleukin-6 (IL-6) and interleukin-8 (IL-8). Thus, these results indicate that the use of human amniotic membrane extracts is a promising treatment for ocular surface disorders accompanied by inflammation.",
keywords = "Anti-inflammatory effect, Human amniotic membrane extract (HAE), Human corneal epithelial cell (hCEC), Interleukin-6 (IL-6), Interleukin-8 (IL-8)",
author = "Lee, {Han Na} and Raymundo Bernardo and Han, {Gi Yeon} and Kim, {Gyu Young} and Kim, {Ji Soo} and Jung, {Won Yong} and Kim, {Keun Nam} and Kim, {Jae Chan} and Kim, {Chan Wha}",
year = "2016",
doi = "10.2485/jhtb.25.282",
language = "English",
volume = "25",
pages = "282--287",
journal = "Journal of Hard Tissue Biology",
issn = "1341-7649",
publisher = "Society of Hard Tissue Regenerative Biology",
number = "3",

}

TY - JOUR

T1 - Human amniotic membrane extracts have anti-inflammatory effects on damaged human corneal epithelial cells in vitro

AU - Lee, Han Na

AU - Bernardo, Raymundo

AU - Han, Gi Yeon

AU - Kim, Gyu Young

AU - Kim, Ji Soo

AU - Jung, Won Yong

AU - Kim, Keun Nam

AU - Kim, Jae Chan

AU - Kim, Chan Wha

PY - 2016

Y1 - 2016

N2 - The human amniotic membrane has therapeutic potential for several diseases such as cardiac ischemia, liver fibrosis, and ocular surface disorders. In the treatment of ocular surface disorders, human amniotic membrane transplantation promotes epithelial wound healing and suppresses inflammation. The objective of this study was to determine whether human amniotic membrane extracts (HAE) help damaged corneal epithelial cells recover from an inflammatory response. Human corneal epithelial cells (hCEC) which were induced inflammation were treated with human amniotic membrane extracts, and then the levels of inflammatory cytokines were measured. Human amniotic membrane extracts had an anti-inflammatory effect on damaged human corneal epithelial cells. More importantly, homogenized human amniotic membrane extracts of less than 3 kDa had a greater capacity for reducing inflammation and secretion of interleukin-6 (IL-6) and interleukin-8 (IL-8). Thus, these results indicate that the use of human amniotic membrane extracts is a promising treatment for ocular surface disorders accompanied by inflammation.

AB - The human amniotic membrane has therapeutic potential for several diseases such as cardiac ischemia, liver fibrosis, and ocular surface disorders. In the treatment of ocular surface disorders, human amniotic membrane transplantation promotes epithelial wound healing and suppresses inflammation. The objective of this study was to determine whether human amniotic membrane extracts (HAE) help damaged corneal epithelial cells recover from an inflammatory response. Human corneal epithelial cells (hCEC) which were induced inflammation were treated with human amniotic membrane extracts, and then the levels of inflammatory cytokines were measured. Human amniotic membrane extracts had an anti-inflammatory effect on damaged human corneal epithelial cells. More importantly, homogenized human amniotic membrane extracts of less than 3 kDa had a greater capacity for reducing inflammation and secretion of interleukin-6 (IL-6) and interleukin-8 (IL-8). Thus, these results indicate that the use of human amniotic membrane extracts is a promising treatment for ocular surface disorders accompanied by inflammation.

KW - Anti-inflammatory effect

KW - Human amniotic membrane extract (HAE)

KW - Human corneal epithelial cell (hCEC)

KW - Interleukin-6 (IL-6)

KW - Interleukin-8 (IL-8)

UR - http://www.scopus.com/inward/record.url?scp=84979085456&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84979085456&partnerID=8YFLogxK

U2 - 10.2485/jhtb.25.282

DO - 10.2485/jhtb.25.282

M3 - Article

AN - SCOPUS:84979085456

VL - 25

SP - 282

EP - 287

JO - Journal of Hard Tissue Biology

JF - Journal of Hard Tissue Biology

SN - 1341-7649

IS - 3

ER -